OpenAlex
PricingAboutJobs
Log inGet started
Work

Fabry disease: overall effects of agalsidase alfa treatment

HTML

Year: 2004
Type: article
Source: European Journal of Clinical Investigation
DOI: 10.1111/j.1365-2362.2004.01424.x
Authors: M. Beck, R. Ricci, U. Widmer, F. Dehout, A. García De Lorenzo, C. Kampmann, A. Linhart, G. Sunder‐Plassmann, G. Houge, U. Ramaswami, A. Gal, A. Mehta
Institutions: Johannes Gutenberg University Mainz, University of Zurich, HUmani - CHU Charleroi-Chimay, Charles University, Medical University of Vienna, Haukeland University Hospital, Addenbrooke's Hospital, Universität Hamburg, The Royal Free Hospital
Language: English

Topic: Lysosomal Storage Disorders Research
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Keywords: Fabry disease, agalsidase alfa, enzyme replacement therapy, alpha-galactosidase A, globotriaosylceramide, renal function, glomerular filtration rate, left ventricular dimensions, cardiac hypertrophy, pain, quality of life, natural history (disease), Fabry Outcome Survey
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2154062927
FWCI: 13.31
Cites: 24
Cited by: 239
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms